Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity.

A Tamir1, W J Jordan, M Ritter

  • 1Department of Immunology, Division of Medicine, Faculty of Medicine, Imperial College at Hammersmith Hospital, London, UK.

Clinical and Experimental Immunology
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Persistent Pulmonary Hypertension and Histologic Chorioamnionitis in Preterm Infants: Controlled Study.

Pediatric cardiology·2018
Same author

Time required to determine performance variables and production efficiency of lactating dairy cows.

Journal of dairy science·2014
Same author

Hypotension during gradual blood loss: waveform variables response and absence of tachycardia.

British journal of anaesthesia·2012
Same author

Outcome and complications of colonoscopy: a prospective multicenter study in northern Israel.

Diagnostic and therapeutic endoscopy·2012
Same author

Prenatal diagnosis of a pulmonary arteriovenous malformation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

Dimensions of the fetal facial profile in normal pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2009
Same journal

Helios expression in naïve CD4+ T cells decreases from neonates to older adults.

Clinical and experimental immunology·2026
Same journal

Could we discuss the molecular signature of immune dysregulation?

Clinical and experimental immunology·2026
Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026
Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026
Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026
Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026
See all related articles

Type I interferons (IFNs), specifically IFN-alpha2a, promote dendritic cell (DC) maturation and enhance T cell responses. However, co-exposure with factors like lipopolysaccharide (LPS) can inhibit these beneficial effects, impacting immunotherapy strategies.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Type I interferons (IFNs) are therapeutically important, but the immunomodulatory effects of IFN-alpha2a on dendritic cells (DCs) are not fully understood.
  • DCs are critical antigen-presenting cells that initiate adaptive immunity by priming naive T cells.
  • Understanding IFN-alpha2a's impact on DC maturation and T cell polarization is crucial for optimizing immunotherapy.

Purpose of the Study:

  • To investigate the effects of IFN-alpha2a on DC maturation and its influence on Th1/Th2 immune responses.
  • To determine how IFN-alpha2a interacts with other maturation stimuli, such as CD40 ligation and lipopolysaccharide (LPS), in modulating DC function.

Main Methods:

  • Phenotypic analysis of DCs treated with IFN-alpha2a, CD40 ligation, and/or LPS.
  • Assessment of cytokine production (IL-10, IL-12, IFN-gamma, IL-5) by DCs and T cells.

Related Experiment Videos

  • Evaluation of T cell priming capacity of IFN-alpha2a-treated DCs.

    • Main Results:

    • IFN-alpha2a alone induced DC maturation and enhanced allostimulatory capacity.
    • Co-stimulation with CD40 ligation and IFN-alpha2a increased IL-10 and IL-12 production.
    • LPS plus IFN-alpha2a primarily induced IL-10, while IFN-alpha2a alone or with CD40 ligation boosted IFN-gamma and IL-5 production by T cells.
    • Concomitant LPS exposure during maturation inhibited the positive effects of IFN-alpha2a on DC phenotype and cytokine profiles.

    Conclusions:

    • IFN-alpha2a effectively promotes DC activation and enhances T cell responses when used alone.
    • The presence of other microbial stimuli like LPS during DC maturation can counteract the beneficial immunomodulatory effects of IFN-alpha2a.
    • These findings have significant implications for the rational design of IFN-alpha-based vaccines and immunotherapies, highlighting the importance of considering the cellular microenvironment.